News

PIKA rabies vaccine is an innovative rabies vaccine independently developed by Yisheng Biopharma, using a novel double-strand RNA analog ("PIKA") which acts as a toll-like receptor-3 (TLR-3) agonist

Auxilium has provided its contractually obligated six-month notice of termination which, absent an agreement between Auxilium and VIVUS for an earlier date, will result in the termination of

This new strategic collaboration is expected to leverage the expertise of Araim Pharmaceuticals in scientific discovery and research with Vault Bioventures’ proven capability in clinical and regulatory development

Under the terms of the agreement with Acerus, Endo will continue to sell and distribute Natesto in the US until the effective date of termination. Acerus president and

Preeclampsia is one of the most common medical complications of pregnancy, and a leading cause of premature births, stillbirths and early neonatal and maternal deaths. Severe preeclampsia occurs

GBT440 is an oral, once-daily SCD therapy that works by increasing hemoglobin’s affinity for oxygen. The company is investigating the drug candidate in both healthy subjects and SCD

This study aims to include CD19-positive Acute Lymphoblastic Leukemia (ALL) patients. Other eligibility criteria to enter clinical trials will be assessed by the investigators. "It has been a

The acquisition provides Agenus the ability to accelerate the development of new cancer vaccines and other single agent immuno-oncology approaches, as well as combination therapies. "PhosImmune’s groundbreaking neoantigen

Patients suffering from these severe gout indications accumulate uric acid deposits in joints and tissues, which can cause debilitating pain and damage to joints and organs. SEL-212, the